Renal Dysfunction Is a Confounder for Plasma Natriuretic Peptides in Detecting Heart Dysfunction in Uremic and Idiopathic Dilated Cardiomyopathies
Author(s) -
Marta Codognotto,
Antonio Piccoli,
Martina Zaninotto,
Monica Mion,
Mario Plebani,
Ugo Vertolli,
Francesco Tona,
Luisa Ruzza,
Agata Barchita,
Giovanni Boffa
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.089656
Subject(s) - medicine , cardiology , natriuretic peptide , atrial natriuretic peptide , dilated cardiomyopathy , heart failure , cardiomyopathy , brain natriuretic peptide , hemodialysis , diastole , dialysis , endocrinology , blood pressure
The diagnostic value of natriuretic peptides in uremic cardiomyopathy has not been defined, nor has the effect of a hemodialysis (HD) session on peptides.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom